ExpreS2ion Biotechnologies is a world leading contract research organisation (CRO) within production in Drosophila Schneider-2 (S2) cells.
For 15 years we have developed, and actively used our proprietary and complete S2 recombinant protein technology ExpreS2.
We have in-depth practical experience with this non-viral Drosophila S2 expression technology for the production of recombinant proteins for research, preclinical development and for use in clinical trials.
- Transfection reagent
- Licenses: Research, Commercial or Manufacturing
- Protein Expression Kits
- Production of proteins for R&D
- Process development for clinical material manufacturing
- Establishment of research cell banks (RCB)